FindTrial
Sign In

EFFECT OF HOMOEOPATHIC MEDICINE FORMICA RUFA & LEDUM PALUSTRE IN THE TREATMENT OF INCREASED URIC ACID IN THE SERUM OF HYPERURICAEMIC PATIENTS

A CLINICAL STUDY ON THE EFFECTIVENESS OF FORMICA RUFA 6 CH & LEDUM PALUTRE 6CH ON TREATING HYPERURICAEMIA - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051544
Enrollment
60
Registered
2023-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

Intervention1: LEDUM PALUTRE 6CH: 5 MEDICATED GLOBULES OF 30 SIZE WILL BE PRESCRIBED ORALLY MORNING AND NIGHT BEFORE FOOD FOR 15 DAYS Intervention2: FORMICA RUFA 6CH: 5 MEDICATED GLOBULES OF 30 SIZE W

Sponsors

VINAYAKA MISSIONS HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITALC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The cases between the age group of 25-60 years of age in both gender who are confirmed by the serum uric acid level screening will be enrolled for the study.

Exclusion criteria

Exclusion criteria: The cases with chronic medical conditions, with extreme co-morbid conditions and patient who are not willing to give consent will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
MODULATION IN THE SERUM URIC ACID LEVELSTimepoint: 15 DAYS—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDRAS SHIVASARAVANAN BHMS MDHOMPHD

VINAYAKA MISSIONS HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

surgery@vmhmc.edu.in9894591770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026